"the LM platform is adxs"
Agree. Likewise, an allogenic solution (off-the-shelf to treat the majority of the masses) using the LM platform to treat/cure cancer (HOT) is really the holy grail, IMO. So...
I'd be surprised if ADXS licenses worldwide rights for HOT in the same way they licensed worldwide rights for NEO. IMO, licensing individual indications for HOT makes more sense, so ADXS doesn't give away everything in a single deal... unless that deal is a buyout of the entire company.
Will be interesting to see how Lombardo and the BOD play it.